The CCNE will develop novel nanomaterials and devices for the improved detection and treatment of cancer. A critical aspect of this process is to test promising materials in the context of tumors in a preclinical setting, preferably in vivo. The Mouse Models Core (MMC) will take advantage of the extensive infrastructure available the MIT Center for Cancer Research for the development and characterization of mouse models of cancer to support the science of the CCNE. The overall function of MMC is to provide technical, methodological and analytical support to each of the Projects in the area of in vivo testing. The Core will function as a centralized resource to establish, maintain and effectively utilize a series of animal models of cancer for the evaluation and preclinical testing of the nanomaterials generated by the individual groups. The MMC will provide a combinatior xenograft tumor models and genetically-engineered mouse models (GEMMs). The Core will import established GEMMs for lung, prostate and brain tumors developed at MIT and elsewhere. It will also use cutting-edge methods in gene targeting to construct additional models tailored to fit the needs of the Projects. It will take advantage the gene targeting and transgenic technologies available from the MIT CCR Transgenic Animal Core Facility The Core will utilize in-house bioluminescence imaging capabilities as well as micro-computed tomography (micro-CT) to follow tumor development and response to therapy for various models. Other imaging technologies will be accessed through the MGH Molecular Imaging Center, including for biodistribution analysis. In addition the provision of mouse cancer models, the MMC staff will carry out efficacy studies for nanomaterial-based therapeutics (Projects 1 and 2). It will also perform dosing and other necessary animal manipulations for imaging based studies, for which imaging will be performed at the MGH Molecular Imaging Center (Projects 3-5). The MMC will be directed by Dr. David Housman (MIT). Dr. Alain Charest (MIT) will directly supervise the activities of the Core and participate in strain construction. Dr. Tyler Jacks will serve as a consultant for the Core.
| Lim, Jong-Min; Cai, Truong; Mandaric, Stefan et al. (2018) Drug loading augmentation in polymeric nanoparticles using a coaxial turbulent jet mixer: Yong investigator perspective. J Colloid Interface Sci 538:45-50 |
| Wei, He; Bruns, Oliver T; Kaul, Michael G et al. (2017) Exceedingly small iron oxide nanoparticles as positive MRI contrast agents. Proc Natl Acad Sci U S A 114:2325-2330 |
| Park, Yong Il; Kim, Eunha; Huang, Chen-Han et al. (2017) Facile Coating Strategy to Functionalize Inorganic Nanoparticles for Biosensing. Bioconjug Chem 28:33-37 |
| Song, Jun; Leon Swisher, Christine; Im, Hyungsoon et al. (2016) Sparsity-Based Pixel Super Resolution for Lens-Free Digital In-line Holography. Sci Rep 6:24681 |
| Nemiroski, A; Ryou, M; Thompson, C C et al. (2015) Swallowable fluorometric capsule for wireless triage of gastrointestinal bleeding. Lab Chip 15:4479-87 |
| Park, Yong Il; Im, Hyungsoon; Weissleder, Ralph et al. (2015) Nanostar Clustering Improves the Sensitivity of Plasmonic Assays. Bioconjug Chem 26:1470-4 |
| Jensen, Russell A; Coropceanu, Igor; Chen, Yue et al. (2015) Thermal Recovery of Colloidal Quantum Dot Ensembles Following Photoinduced Dimming. J Phys Chem Lett 6:2933-7 |
| Veiseh, Omid; Doloff, Joshua C; Ma, Minglin et al. (2015) Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat Mater 14:643-51 |
| Lee, Hakho; Shin, Tae-Hyun; Cheon, Jinwoo et al. (2015) Recent Developments in Magnetic Diagnostic Systems. Chem Rev 115:10690-724 |
| Glenn, D R; Lee, K; Park, H et al. (2015) Single-cell magnetic imaging using a quantum diamond microscope. Nat Methods 12:736-738 |
Showing the most recent 10 out of 174 publications
